lobbying_activities: 2065245

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2065245	e6fac8a1-5803-4262-b4c6-57db3aceb96b	Q4	WINNING STRATEGIES WASHINGTON	50796	KALEO	2017	fourth_quarter	PHA	Pharmaceutical drug development including epinephrine for anaphylaxis	Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE	30000		0	0	2018-01-17T14:00:34.160000-05:00